APA (7th ed.) Citation

C, C., MAM, S., GN, d. C. F., EZ, K., AE, F., ME, d. M., & MC, M. (2025). Combination of sibutramine and topiramate for the treatment of obesity: The SIBAMATE retrospective cohort study : Sibutramine and topiramate for the treatment of obesity. Diabetology & metabolic syndrome, 17(1), 289. https://doi.org/10.1186/s13098-025-01842-1

Chicago Style (17th ed.) Citation

C, Cercato, Stumpf MAM, da Cunha Freire GN, Kawahara EZ, Fernandes AE, de Melo ME, and Mancini MC. "Combination of Sibutramine and Topiramate for the Treatment of Obesity: The SIBAMATE Retrospective Cohort Study : Sibutramine and Topiramate for the Treatment of Obesity." Diabetology & Metabolic Syndrome 17, no. 1 (2025): 289. https://doi.org/10.1186/s13098-025-01842-1.

MLA (9th ed.) Citation

C, Cercato, et al. "Combination of Sibutramine and Topiramate for the Treatment of Obesity: The SIBAMATE Retrospective Cohort Study : Sibutramine and Topiramate for the Treatment of Obesity." Diabetology & Metabolic Syndrome, vol. 17, no. 1, 2025, p. 289, https://doi.org/10.1186/s13098-025-01842-1.